(Q54596100)

English

Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up or acute myeloid leukaemia transformation: incidence and their prognostic significance.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up or acute myeloid leukaemia transformation: incidence and their prognostic significance. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

1 reference

based on heuristic

inferred from title

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

author name string

Georgios Georgiou

1

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Vasiliki Karali

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Christina Zouvelou

3

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Elias Kyriakou

4

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Maria Dimou

5

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Stamatis Chrisochoou

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Paraskevi Greka

7

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Dimitrios Dufexis

8

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Elisavet Vervesou

9

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Evaggelia Dimitriadou

10

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Anna Efthymiou

11

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Loizos Petrikkos

12

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Katerina Dima

13

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Konstantinos Lilakos

14

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Panayiotis Panayiotidis

15

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

language of work or name

0 references

publication date

20 June 2006

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

British Journal of Haematology

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

134

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

3

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

302-306

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06171.X

21 January 2018

FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06171.X

21 January 2018

Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06171.X

21 January 2018

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06171.X

21 January 2018

RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06171.X

21 January 2018

The Day One Talk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06171.X

21 January 2018

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06171.X

21 January 2018

Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06171.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2006.06171.X

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16787503

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54596100&oldid=1519716710"